Caldera Therapeutics · Boston tech scene from Fundable · PamPam
Caldera Therapeutics
Caldera Therapeutics is a clinical-stage biotech developing CLD-423, a first-in-class bispecific antibody for inflammatory bowel disease and other immune-mediated disorders.